Construction of anti-calcification small-diameter vascular grafts using decellularized extracellular matrix/poly (L-lactide-co-ε-caprolactone) and baicalin-cathepsin S inhibitor

IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL
Yanjiao Teng , Xiaohai Zhang , Lin Song , Jianing Yang , Duo Li , Ziqi Shi , Xiaoqin Guo , Shufang Wang , Haojun Fan , Li Jiang , Shike Hou , Seeram Ramakrishna , Qi Lv , Jie Shi
{"title":"Construction of anti-calcification small-diameter vascular grafts using decellularized extracellular matrix/poly (L-lactide-co-ε-caprolactone) and baicalin-cathepsin S inhibitor","authors":"Yanjiao Teng ,&nbsp;Xiaohai Zhang ,&nbsp;Lin Song ,&nbsp;Jianing Yang ,&nbsp;Duo Li ,&nbsp;Ziqi Shi ,&nbsp;Xiaoqin Guo ,&nbsp;Shufang Wang ,&nbsp;Haojun Fan ,&nbsp;Li Jiang ,&nbsp;Shike Hou ,&nbsp;Seeram Ramakrishna ,&nbsp;Qi Lv ,&nbsp;Jie Shi","doi":"10.1016/j.actbio.2025.03.033","DOIUrl":null,"url":null,"abstract":"<div><div>The long-term transplantation of small-diameter vascular grafts (SDVGs) is associated with a risk of calcification, which is a key factor limiting the clinical translation of SDVG. Hence, there is an urgency attached to the development of new SDVGs with anti-calcification properties. Here, we used decellularized extracellular matrix (dECM) and poly (L-lactide-co-ε-caprolactone) (PLCL) as base materials and combined these with baicalin, cathepsin S (Cat S) inhibitor to prepare PBC-SDVGs by electrospinning. Baicalin contains carboxyl and hydroxyl groups that can interact with chemical groups in dECM powder, potentially blocking calcium nucleation sites. Cat S inhibitor prevents elastin degradation and further reduces the risk of calcification. PBC-SDVGs were biocompatible and when implanted in rat abdominal aorta, accelerated endothelialization, enhanced vascular tissue regeneration, inhibited elastin degradation, and promoted macrophage polarization M2 phenotype to regulate inflammation. After 3 months of implantation, the results of Doppler ultrasound, MicroCT, and histological staining revealed a significant reduction in calcification. In summary, the developed anti-calcification SDVGs offer a promising strategy for long-term implantation with significant clinical application potential.</div></div><div><h3>Statement of Significance</h3><div>The dECM and PLCL were used as base materials, connected with baicalin, and loaded with Cat S inhibitor to prepare PBC-SDVGs. The baicalin and dECM powder formed hydrogen bonds to crosslink together reducing the calcium deposition. <em>In vitro</em>, the vascular graft downregulated the expression level of osteogenic genes and promoted macrophage polarization toward an anti-inflammatory M2 phenotype, thereby reducing calcification. The PBC-SDVGs implanted in rat abdominal aorta can accelerate endothelialization, enhance vascular tissue regeneration, inhibit elastin degradation, reduce inflammation response and calcification.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"197 ","pages":"Pages 184-201"},"PeriodicalIF":9.4000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomaterialia","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1742706125002065","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

The long-term transplantation of small-diameter vascular grafts (SDVGs) is associated with a risk of calcification, which is a key factor limiting the clinical translation of SDVG. Hence, there is an urgency attached to the development of new SDVGs with anti-calcification properties. Here, we used decellularized extracellular matrix (dECM) and poly (L-lactide-co-ε-caprolactone) (PLCL) as base materials and combined these with baicalin, cathepsin S (Cat S) inhibitor to prepare PBC-SDVGs by electrospinning. Baicalin contains carboxyl and hydroxyl groups that can interact with chemical groups in dECM powder, potentially blocking calcium nucleation sites. Cat S inhibitor prevents elastin degradation and further reduces the risk of calcification. PBC-SDVGs were biocompatible and when implanted in rat abdominal aorta, accelerated endothelialization, enhanced vascular tissue regeneration, inhibited elastin degradation, and promoted macrophage polarization M2 phenotype to regulate inflammation. After 3 months of implantation, the results of Doppler ultrasound, MicroCT, and histological staining revealed a significant reduction in calcification. In summary, the developed anti-calcification SDVGs offer a promising strategy for long-term implantation with significant clinical application potential.

Statement of Significance

The dECM and PLCL were used as base materials, connected with baicalin, and loaded with Cat S inhibitor to prepare PBC-SDVGs. The baicalin and dECM powder formed hydrogen bonds to crosslink together reducing the calcium deposition. In vitro, the vascular graft downregulated the expression level of osteogenic genes and promoted macrophage polarization toward an anti-inflammatory M2 phenotype, thereby reducing calcification. The PBC-SDVGs implanted in rat abdominal aorta can accelerate endothelialization, enhance vascular tissue regeneration, inhibit elastin degradation, reduce inflammation response and calcification.

Abstract Image

脱细胞细胞外基质/聚l-乳酸-co-ε-己内酯和黄芩苷-组织蛋白酶S抑制剂构建抗钙化小直径血管移植物。
小直径血管移植(SDVG)长期移植存在钙化风险,这是限制SDVG临床应用的关键因素。因此,迫切需要开发具有抗钙化性能的新型sdgs。本研究以脱细胞胞外基质(dECM)和聚l -乳酸-co-ε-己内酯(PLCL)为基料,与黄芩苷、组织蛋白酶S (Cat S)抑制剂结合,采用静电纺丝法制备pbc - sdgs。黄芩苷含有羧基和羟基,可以与dECM粉末中的化学基团相互作用,潜在地阻断钙成核位点。Cat S抑制剂防止弹性蛋白降解,进一步降低钙化的风险。pbc - sdgs具有生物相容性,植入大鼠腹主动脉后,加速内皮化,增强血管组织再生,抑制弹性蛋白降解,促进巨噬细胞极化M2表型,调节炎症。植入3个月后,多普勒超声、显微ct和组织学染色结果显示钙化明显减少。综上所述,所开发的抗钙化sdgs为长期植入提供了一种有前景的策略,具有重要的临床应用潜力。意义说明:以dECM和PLCL为基料,与黄芩苷连接,负载Cat S抑制剂制备pbc - sdgs。黄芩苷与dECM粉末形成氢键交联,减少钙沉积。在体外,血管移植物下调成骨基因的表达水平,促进巨噬细胞向抗炎M2表型极化,从而减少钙化。pbc - sdgs植入大鼠腹主动脉后,可加速血管内皮化,增强血管组织再生,抑制弹性蛋白降解,减轻炎症反应和钙化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Biomaterialia
Acta Biomaterialia 工程技术-材料科学:生物材料
CiteScore
16.80
自引率
3.10%
发文量
776
审稿时长
30 days
期刊介绍: Acta Biomaterialia is a monthly peer-reviewed scientific journal published by Elsevier. The journal was established in January 2005. The editor-in-chief is W.R. Wagner (University of Pittsburgh). The journal covers research in biomaterials science, including the interrelationship of biomaterial structure and function from macroscale to nanoscale. Topical coverage includes biomedical and biocompatible materials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信